GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
+39.59%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$587M
AUM Growth
+$587M
Cap. Flow
-$98.3M
Cap. Flow %
-16.76%
Top 10 Hldgs %
58.11%
Holding
50
New
10
Increased
7
Reduced
12
Closed
15

Top Buys

1
NGNE icon
Neurogene
NGNE
$19.3M
2
ABVX
Abivax
ABVX
$16.6M
3
TRML icon
Tourmaline Bio
TRML
$15M
4
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$11.9M
5
ARVN icon
Arvinas
ARVN
$9.63M

Top Sells

1
PNT
POINT Biopharma Global Inc. Common Stock
PNT
$19.4M
2
ACLX icon
Arcellx
ACLX
$13.3M
3
ACRS icon
Aclaris Therapeutics
ACRS
$11.6M
4
PTCT icon
PTC Therapeutics
PTCT
$11.2M
5
REPL icon
Replimune Group
REPL
$10.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SRPT icon
26
Sarepta Therapeutics
SRPT
$1.98B
$7.71M 1.31%
80,000
-85,200
-52% -$8.22M
INSM icon
27
Insmed
INSM
$30.3B
$7M 1.19%
225,912
-168,960
-43% -$5.24M
PBYI icon
28
Puma Biotechnology
PBYI
$258M
$4.73M 0.81%
+1,093,273
New +$4.73M
OCUL icon
29
Ocular Therapeutix
OCUL
$2.25B
$3.12M 0.53%
+700,000
New +$3.12M
SYRE icon
30
Spyre Therapeutics
SYRE
$1.02B
$2.69M 0.46%
+125,000
New +$2.69M
ACLX icon
31
Arcellx
ACLX
$3.95B
$2.68M 0.46%
48,264
-239,236
-83% -$13.3M
MRUS icon
32
Merus
MRUS
$5.04B
$550K 0.09%
+20,000
New +$550K
AXSM icon
33
Axsome Therapeutics
AXSM
$6.09B
$395K 0.07%
+4,963
New +$395K
MURA icon
34
Mural Oncology
MURA
$35.9M
$68.1K 0.01%
+11,509
New +$68.1K
ABOS icon
35
Acumen Pharmaceuticals
ABOS
$84.2M
– –
-1,074,101
Closed -$4.46M
ACRS icon
36
Aclaris Therapeutics
ACRS
$223M
– –
-1,691,768
Closed -$11.6M
AKRO icon
37
Akero Therapeutics
AKRO
$3.65B
– –
-198,500
Closed -$10M
GBIO icon
38
Generation Bio
GBIO
$40.3M
– –
-1,022,537
Closed -$3.88M
GOSS icon
39
Gossamer Bio
GOSS
$587M
– –
-6,230,272
Closed -$5.19M
HRTX icon
40
Heron Therapeutics
HRTX
$204M
– –
-4,737,368
Closed -$4.88M
IGMS
41
DELISTED
IGM Biosciences
IGMS
– –
-615,317
Closed -$5.14M
PTCT icon
42
PTC Therapeutics
PTCT
$4.41B
– –
-500,000
Closed -$11.2M
REPL icon
43
Replimune Group
REPL
$460M
– –
-638,495
Closed -$10.9M
SLDB icon
44
Solid Biosciences
SLDB
$448M
– –
-450,403
Closed -$1.14M
OKUR
45
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
– –
-1,167,061
Closed -$8.89M
CERE
46
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-215,000
Closed -$4.69M
AMAM
47
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
– –
0
– –
GRCL
48
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
– –
-579,667
Closed -$1.67M
MRTX
49
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-86,302
Closed -$3.76M
PNT
50
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-2,909,960
Closed -$19.4M
1
2